AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3881654 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A
Number of subjects: 34
Study 3881654 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (azathioprine, prednisone, antithymocyte immunoglobulin)
Number of subjects: 34
Study 31058977 — intervention group
Group type: EXPERIMENTAL
Intervention: HSV529 vaccine
Number of subjects: 60
Study 31058977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 29781955 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-centered care intervention (n = 31)
Number of subjects: 61
Study 29781955 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 61
Study 26419905 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in the study
Number of subjects: 26
Study 26419905 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitators of participation
Number of subjects: 26
Study 26419905 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to participation
Number of subjects: 26
Study 24373998 — intervention group
Group type: EXPERIMENTAL
Intervention: PT302 (4 mg)
Number of subjects: 34
Study 24373998 — intervention group
Group type: EXPERIMENTAL
Intervention: PT302 (0.5 mg, 1 mg, 2 mg, 4 mg)
Number of subjects: 34
Study 22990142 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram alone
Number of subjects: 86
Study 22990142 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram + IPT
Number of subjects: 86
Study 22990142 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram alone and Escitalopram + IPT
Number of subjects: 86
Study 20160750 — intervention group
Group type: EXPERIMENTAL
Intervention: FA‐ADEK (fat‐soluble vitamins A,D,E,K plus fatty acids alpha‐linolenic acid (ALA), docosahexaenoic acid (DHA) and medium‐chain triglycerides)
Number of subjects: 48
Study 20160750 — intervention group
Group type: COMPARATOR
Intervention: ADEK (fat‐soluble vitamins A,D,E,K)
Number of subjects: 48
Study 20160750 — intervention group
Group type: EXPERIMENTAL
Intervention: FA‐ADEK
Number of subjects: 48
Study 20160750 — intervention group
Group type: COMPARATOR
Intervention: ADEK
Number of subjects: 48
Study 18839781 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly active antiretroviral therapy (HAART; zidovudine [ZDV], lamivudine, and nevirapine [NVP])
Number of subjects: 58
Study 18839781 — intervention group
Group type: COMPARATOR
Intervention: Short-course ZDV plus single-dose NVP (ZDV/NVP)
Number of subjects: 58
Study 16025317 — intervention group
Group type: EXPERIMENTAL
Intervention: zopiclone (7.5 mg)
Number of subjects: 23
Study 16025317 — intervention group
Group type: EXPERIMENTAL
Intervention: lormetazepam (1 mg)
Number of subjects: 23
Study 16025317 — intervention group
Group type: EXPERIMENTAL
Intervention: zolpidem (10 mg)
Number of subjects: 23
Study 16025317 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 23
Study 11986476 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course antibiotic therapy (</=3 days)
Number of subjects: 16
Study 11986476 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course antibiotic therapy (single-dose or 1-day)
Number of subjects: 16
Study 11986476 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course antibiotic therapy (3-day)
Number of subjects: 16
Study 11986476 — intervention group
Group type: COMPARATOR
Intervention: Long-course antibiotic therapy (7-14 days)
Number of subjects: 16
Study 10524723 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group received additional information about stop signals (three oral, one written) before injections.
Number of subjects: 36
Study 10524723 — intervention group
Group type: COMPARATOR
Intervention: Control group received standard information leaflet only.
Number of subjects: 36
Study 7761218 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy at home
Number of subjects: 14
Study 7761218 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy in the hospital
Number of subjects: 14
Study 2148014 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 20 mg TID
Number of subjects: 8
Study 2148014 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone (DP) 20 mg TID
Number of subjects: 8
Study 2148014 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of MPA and DP
Number of subjects: 8
Study 2148014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 6985836 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole (150 mg daily x 3)
Number of subjects: 100
Study 6985836 — intervention group
Group type: COMPARATOR
Intervention: Control (no Levamisole)
Number of subjects: 100
Study 6985836 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients (100 total)
Number of subjects: 100
Study 31826731 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy
Number of subjects: 182
Study 31826731 — intervention group
Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 182
Study 31752785 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day mobile health education intervention
Number of subjects: 3360
Study 28954877 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training with virtual reality (TT + VR)
Number of subjects: 34
Study 28954877 — intervention group
Group type: COMPARATOR
Intervention: Treadmill training (TT)
Number of subjects: 34
Study 25491704 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy only
Number of subjects: 16
Study 25491704 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy combined with motivational interviewing and a peer support group
Number of subjects: 16
Study 24410783 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour telephone specialist support line
Number of subjects: 52
Study 24410783 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 52
Study 21571149 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel-coated coils
Number of subjects: 499
Study 21571149 — intervention group
Group type: COMPARATOR
Intervention: Control (bare platinum coils)
Number of subjects: 499
Study 19906763 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS + exercise
Number of subjects: 109
Study 19906763 — intervention group
Group type: COMPARATOR
Intervention: TENS
Number of subjects: 109
Study 19906763 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation + exercise
Number of subjects: 109
Study 19906763 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 109
Study 16951028 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroquinolones (ciprofloxacin)
Number of subjects: 520000
Study 14764980 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Number of subjects: 10
Study 11500190 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 328
Study 9737478 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin, ticlopidine, and aspirin
Number of subjects: 0
Study 9737478 — intervention group
Group type: COMPARATOR
Intervention: Warfarin anticoagulant treatment
Number of subjects: 0
Study 8144734 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun Plak Control electric toothbrush
Number of subjects: 77
Study 8144734 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 77
Study 3416147 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiocassette tape
Number of subjects: 177
Study 3416147 — intervention group
Group type: EXPERIMENTAL
Intervention: Self management booklet
Number of subjects: 177
Study 3416147 — intervention group
Group type: EXPERIMENTAL
Intervention: Both the book and tape
Number of subjects: 177
Study 3416147 — intervention group
Group type: COMPARATOR
Intervention: Neither (control group)
Number of subjects: 177
Study 3416147 — intervention group
Group type: EXPERIMENTAL
Intervention: Book alone
Number of subjects: 177
Study 3416147 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups given the material
Number of subjects: 177
Study 1332102 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin-2 and lymphokine-activated killer cells
Number of subjects: 8
Study 1332102 — intervention group
Group type: COMPARATOR
Intervention: No active treatment (Control)
Number of subjects: 8
Study 718066 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiation therapy and surgery
Number of subjects: 110
Study 718066 — intervention group
Group type: COMPARATOR
Intervention: Surgery and postoperative radiation therapy
Number of subjects: 110
Study 31449857 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 29340496 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-month supervised maintenance exercise program (24MME group)
Number of subjects: 63
Study 29340496 — intervention group
Group type: COMPARATOR
Intervention: 27-month physical activity counseling program (27MPAC group)
Number of subjects: 63
Study 25202849 — intervention group
Group type: EXPERIMENTAL
Intervention: %HRR before allo‐HCT
Number of subjects: 106
Study 25202849 — intervention group
Group type: EXPERIMENTAL
Intervention: %HRmax before allo‐HCT
Number of subjects: 106
Study 25202849 — intervention group
Group type: EXPERIMENTAL
Intervention: %VO2max before allo‐HCT
Number of subjects: 106
Study 25202849 — intervention group
Group type: EXPERIMENTAL
Intervention: %HRR 180 days after allo‐HCT
Number of subjects: 106
Study 25202849 — intervention group
Group type: EXPERIMENTAL
Intervention: %HRmax 180 days after allo‐HCT
Number of subjects: 106
Study 25202849 — intervention group
Group type: EXPERIMENTAL
Intervention: %VO2max 180 days after allo‐HCT
Number of subjects: 106
Study 23047980 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Open Airways for Schools (OAS) asthma education program
Number of subjects: 0
Study 23047980 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 21718265 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly resistance training
Number of subjects: 123
Study 21718265 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly resistance training
Number of subjects: 123
Study 21718265 — intervention group
Group type: COMPARATOR
Intervention: Twice-weekly balance and tone exercises (control)
Number of subjects: 123
Study 18640743 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 106
Study 18640743 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 106
Study 18640743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 17322994 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (EST)
Number of subjects: 180
Study 17322994 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic papillary balloon dilation (EPBD)
Number of subjects: 180
Study 12740733 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic training group (HG)
Number of subjects: 12
Study 12740733 — intervention group
Group type: COMPARATOR
Intervention: Normoxic training group (NG)
Number of subjects: 12
Study 10952639 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse clerking
Number of subjects: 60
Study 10952639 — intervention group
Group type: COMPARATOR
Intervention: Senior house officer (SHO) clerking
Number of subjects: 60
Study 8788535 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive coping skills training (three 45-min sessions)
Number of subjects: 64
Study 8788535 — intervention group
Group type: COMPARATOR
Intervention: Disease-education control (three 45-min didactic-discussion sessions about SCD)
Number of subjects: 64
Study 1281624 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 30
Study 1281624 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 30
Study 6690008 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunochemotherapy (OK-432)
Number of subjects: 211
Study 6690008 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 211
Study 30626270 — intervention group
Group type: EXPERIMENTAL
Intervention: PADS intervention (lesson plans and activities embedded into Massachusetts early learning standards, implemented for 4 days per week for 12 weeks)
Number of subjects: 114
Study 30626270 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual curriculum)
Number of subjects: 114
Study 27388250 — intervention group
Group type: EXPERIMENTAL
Intervention: Transepithelial CXL
Number of subjects: 144
Study 27388250 — intervention group
Group type: COMPARATOR
Intervention: Epithelium-off CXL
Number of subjects: 144
Study 26363985 — intervention group
Group type: EXPERIMENTAL
Intervention: Locoregional treatment
Number of subjects: 350
Study 26363985 — intervention group
Group type: COMPARATOR
Intervention: No locoregional treatment
Number of subjects: 350
Study 23872530 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration training (WBV) in adolescents with Down syndrome (VDSG)
Number of subjects: 57
Study 23872530 — intervention group
Group type: COMPARATOR
Intervention: Whole Body Vibration training (WBV) in adolescents without Down syndrome (VCG)
Number of subjects: 57
Study 23872530 — intervention group
Group type: COMPARATOR
Intervention: No Whole Body Vibration training (nVDSG) in adolescents with Down syndrome
Number of subjects: 57
Study 23872530 — intervention group
Group type: COMPARATOR
Intervention: No Whole Body Vibration training (nVCG) in adolescents without Down syndrome
Number of subjects: 57
Study 21156001 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calcium diet + probiotic (2 g/kg diet)
Number of subjects: 25
Study 21156001 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calcium diet + prebiotic (2 g/kg diet)
Number of subjects: 25
Study 21156001 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calcium diet + synbiotic (mix of probiotic and prebiotic, each 2 g/kg diet)
Number of subjects: 25
Study 21156001 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calcium diet + organic acid (1.5 g/kg diet)
Number of subjects: 25
Study 21156001 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calcium diet (0.67%) without any additive
Number of subjects: 25
Study 21156001 — intervention group
Group type: COMPARATOR
Intervention: Basal diet containing recommended level of calcium (0.9%)
Number of subjects: 25
Study 19922882 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan (40 mg/d)
Number of subjects: 70
Study 19922882 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (5 mg/d)
Number of subjects: 70
Study 19922882 — intervention group
Group type: EXPERIMENTAL
Intervention: Both telmisartan and enalapril
Number of subjects: 70
Study 17097814 — intervention group
Group type: EXPERIMENTAL
Intervention: exercise+nicotine patch
Number of subjects: 142
Study 17097814 — intervention group
Group type: COMPARATOR
Intervention: exercise+no nicotine patch
Number of subjects: 142
Study 17097814 — intervention group
Group type: EXPERIMENTAL
Intervention: cognitive behavior therapy (CBT)+nicotine patch
Number of subjects: 142
Study 17097814 — intervention group
Group type: COMPARATOR
Intervention: CBT+no nicotine patch
Number of subjects: 142
Study 14993020 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group 18 to 30 years
Number of subjects: 3076
Study 14993020 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group 31 to 40 years
Number of subjects: 3076
Study 14993020 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group 41 to 50 years
Number of subjects: 3076
Study 14993020 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group 51 to 60 years
Number of subjects: 3076
Study 14993020 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group 61 to 70 years
Number of subjects: 3076
Study 14993020 — intervention group
Group type: EXPERIMENTAL
Intervention: All age groups
Number of subjects: 3076
Study 11252465 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-week static stretching protocol
Number of subjects: 40
Study 11252465 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-week static stretching protocol
Number of subjects: 40
Study 11252465 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 9869343 — intervention group
Group type: EXPERIMENTAL
Intervention: Free conjunctival autograft (FCG)
Number of subjects: 54
Study 9869343 — intervention group
Group type: COMPARATOR
Intervention: Postoperative strontium 90 (90Sr) beta-irradiation
Number of subjects: 54
Study 8363392 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxacin (200 mg/12 h for 3 days)
Number of subjects: 0
Study 8363392 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime axetil (125 mg/12 h for 7 days)
Number of subjects: 0
Study 8363392 — intervention group
Group type: COMPARATOR
Intervention: Enoxacin and Cefuroxime axetil
Number of subjects: 0
Study 3534857 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 25 mg every 8 hours for 1 month
Number of subjects: 0
Study 3534857 — intervention group
Group type: COMPARATOR
Intervention: Digoxin 0.25 mg once a day for 1 month
Number of subjects: 0
Study 31291923 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalization-Based Treatment (MBT)
Number of subjects: 36
Study 31291923 — intervention group
Group type: COMPARATOR
Intervention: Usual Clinical Care (UCC)
Number of subjects: 36
Study 26888146 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human (rh)IGF‐I/rhIGF binding protein‐3 (IGFBP‐3) complex (30 mg/day)
Number of subjects: 56
Study 26888146 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human (rh)IGF‐I/rhIGF binding protein‐3 (IGFBP‐3) complex (60 mg/day)
Number of subjects: 56
Study 26888146 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 56
Study 26888146 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human (rh)IGF‐I/rhIGF binding protein‐3 (IGFBP‐3) complex (30 mg/day or 60 mg/day)
Number of subjects: 56
Study 26006260 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP) with chloroquine taken once
Number of subjects: 0
Study 26006260 — intervention group
Group type: EXPERIMENTAL
Intervention: Three courses of SP with azithromycin
Number of subjects: 0
Study 26006260 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 0
Study 26006260 — intervention group
Group type: COMPARATOR
Intervention: Malaria prevention regimen
Number of subjects: 0
Study 24081940 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine and soy protein powder
Number of subjects: 120
Study 24081940 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine and milk protein powder
Number of subjects: 120
Study 24081940 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein powder and placebo pill
Number of subjects: 120
Study 24081940 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine and placebo pill
Number of subjects: 120
Study 21725874 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% KZC and 2% TET cream (KCZ + TET group)
Number of subjects: 97
Study 21725874 — intervention group
Group type: COMPARATOR
Intervention: 2% KZC cream (KCZ group)
Number of subjects: 97
Study 21725874 — intervention group
Group type: COMPARATOR
Intervention: 2% TET cream (TET group)
Number of subjects: 97
Study 19370276 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.075 mg/kg and Dexamethasone 10 mg (MD group)
Number of subjects: 80
Study 19370276 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.075 mg/kg (M group)
Number of subjects: 80
Study 19370276 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 10 mg (D group)
Number of subjects: 80
Study 19370276 — intervention group
Group type: COMPARATOR
Intervention: Intravenous normal saline (S group)
Number of subjects: 80
Study 16468112 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured outpatient follow-up care consisting of 12 half-hour consultations by primary care physicians utilizing a modular consultation guideline and an internet-based training programme.
Number of subjects: 521
Study 16468112 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 521
Study 16468112 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured outpatient follow-up care.
Number of subjects: 521
Study 15329905 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (20 Gray [Gy]/10 fractions to a modified pelvic volume)
Number of subjects: 22
Study 11127936 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 60
Study 11127936 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 60
Study 9133516 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (n=12)
Number of subjects: 25
Study 9133516 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=13)
Number of subjects: 25
Study 7697311 — intervention group
Group type: EXPERIMENTAL
Intervention: Art Future Image Intervention (AFI)
Number of subjects: 158
Study 7697311 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 158
Study 3665957 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose anticoagulants
Number of subjects: 21
Study 3665957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 3665957 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral warfarin
Number of subjects: 21
Study 3665957 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-warfarin discontinuation
Number of subjects: 21
Study 3665957 — intervention group
Group type: EXPERIMENTAL
Intervention: Apical akinesis at 10 days
Number of subjects: 21
Study 3665957 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with LV thrombi
Number of subjects: 21
Study 29410448 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 45
Study 29410448 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic use
Number of subjects: 45
Study 29410448 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth mode
Number of subjects: 45
Study 28070786 — intervention group
Group type: EXPERIMENTAL
Intervention: Volunteer Advocacy Program-Transition (VAP-T)
Number of subjects: 41
Study 26403905 — intervention group
Group type: EXPERIMENTAL
Intervention: Driver support application with phone blocking (N=92)
Number of subjects: 182
Study 26403905 — intervention group
Group type: EXPERIMENTAL
Intervention: Driver support application with phone blocking and parental monitoring (N=90)
Number of subjects: 182
Study 26403905 — intervention group
Group type: COMPARATOR
Intervention: Control group with application recording phone use (N=92)
Number of subjects: 182